Annis Gardner Whiting Capital Advisors, LLC Charles River Laboratories International, Inc. Transaction History
Annis Gardner Whiting Capital Advisors, LLC
- $355 Billion
- Q3 2024
A detailed history of Annis Gardner Whiting Capital Advisors, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Annis Gardner Whiting Capital Advisors, LLC holds 56 shares of CRL stock, worth $9,134. This represents 0.0% of its overall portfolio holdings.
Number of Shares
56
Previous 56
-0.0%
Holding current value
$9,134
Previous $11.6 Million
4.65%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CRL
# of Institutions
692Shares Held
51.7MCall Options Held
259KPut Options Held
463K-
Vanguard Group Inc Valley Forge, PA6.1MShares$995 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$830 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.74MShares$610 Million0.13% of portfolio
-
State Street Corp Boston, MA2.13MShares$347 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.94MShares$316 Million0.87% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $8.3B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...